ALLISON KOBLITZ: Open Payments
NPI 1639548175 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 6 payments from 6 companies in 2025. Trend: 2023 $88 · 2024 $97 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 1 | $149 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Genmab U.S., Inc. | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $91 |
Products named: ELZONRIS, ICLUSIG, Epkinly, RYBREVANT, REBLOZYL.
Industry payments across FL — which companies pay providers there.
